Pharmacology, Toxicology and Pharmaceutical Science
Ovary Cancer
100%
Neoplasm
86%
Malignant Neoplasm
83%
Small Interfering RNA
71%
Liposome
62%
Amphotericin B
46%
microRNA
44%
Tumor Growth
40%
Breast Cancer
31%
Retinoic Acid
27%
Ovary Carcinoma
24%
Cancer Growth
22%
Pharmacokinetic
19%
Chemotherapy
18%
Mouse Model
18%
Metastasis
16%
Cisplatin
15%
Drug Resistance
15%
Protein Glutamine Gamma Glutamyltransferase
14%
Diseases
13%
Combination Therapy
13%
Nanoparticle
12%
Lipoprotein
11%
Egg Lecithin
11%
Promyelocytic Leukemia
10%
Antisense Oligonucleotide
10%
Paclitaxel
9%
Phosphotransferase
9%
Messenger RNA
9%
Retinoid
9%
Candidiasis
9%
Carcinogenesis
8%
Receptor
8%
microRNA 34a
8%
Antifungal Activity
8%
Tumor Suppressor Protein
8%
Candida albicans
8%
Biological Marker
8%
Systemic Mycosis
8%
Cytotoxicity
7%
Tumor Necrosis Factor
7%
Chitosan Nanoparticle
7%
Therapeutic Effect
7%
Antitumor Activity
7%
Prostate Cancer
7%
Nystatin
7%
Growth Factor Receptor Bound Protein 2
6%
Ciclosporin
6%
Amphotericin B Lipid Complex
6%
Triple Negative Breast Cancer
6%
Medicine and Dentistry
Ovarian Cancer
91%
Cancer Cell
41%
Neoplasm
40%
Small Interfering RNA
40%
Tumor Progression
38%
microRNA
31%
Metastatic Carcinoma
28%
Malignant Neoplasm
27%
Krukenberg Tumor
26%
Breast Cancer
25%
Programmed Cell Death
23%
Liposome
22%
In Vitro
19%
Cancer Growth
18%
Angiogenesis
13%
Tumor Cell
12%
Cancer
11%
Cisplatin
11%
Carcinogenesis
10%
Tumor Microenvironment
10%
Drug Resistance
10%
Amphotericin B
10%
Antiangiogenic Therapy
9%
Cell Proliferation
9%
Paclitaxel
9%
Endothelial Cell
8%
Upregulation
8%
Triple Negative Breast Cancer
8%
Vasculotropin
8%
4 Iodo 2,5 Dimethoxyamphetamine
8%
Uterine Cancer
8%
Focal Adhesion Kinase
8%
Janus Kinase 1
8%
Xenograft
8%
Protein P53
8%
Autophagy
7%
Phosphotransferase
7%
Biological Marker
7%
Cancer Therapy
7%
Macrophage
7%
Cell Death
7%
Combination Therapy
7%
Tumor Suppressor Protein
7%
Antineoplastic Activity
7%
Egg Lecithin
6%
Protein Kinase B
6%
Antisense Oligonucleotide
6%
Tumor Angiogenesis
6%
Downregulation
6%
Receptor
6%
Keyphrases
Ovarian Cancer
73%
Small Interfering RNA (siRNA)
45%
Liposomal
27%
Tumor Growth
25%
Liposomes
24%
MicroRNA
24%
In Cancer
23%
Amphotericin B
22%
Tumor
22%
All-trans Retinoic Acid
17%
Ovarian Cancer Cells
17%
Liposomal Amphotericin B
16%
Ovarian Carcinoma
15%
Non-coding RNA (ncRNA)
15%
Breast Cancer
15%
Liposome-encapsulated
13%
Tumor Angiogenesis
12%
Therapeutic Targeting
11%
Cancer Cells
11%
Human Peripheral Blood Monocytes
10%
B-cell Lymphoma 2 (Bcl-2)
10%
Angiogenesis
10%
Tissue Transglutaminase
10%
Clinical Cancer Research
10%
Macrophages
10%
Tumor Cells
10%
Antisense Oligonucleotides
9%
Antitumor Effect
9%
Triple-negative Breast Cancer
9%
Monocytes
9%
Therapeutic Target
9%
Long Non-coding RNA (LncRNA)
8%
Breast Cancer Cells
8%
Blood Monocytes
8%
Human Blood
8%
Phosphatidylcholine
8%
Tumor Progression
8%
RNA Interference
8%
Anti-angiogenesis
8%
Apoptosis
8%
Nanoparticles
8%
Pharmacokinetics
8%
Cancer Growth
8%
Acute Promyelocytic Leukemia
7%
Metastasis
7%
Antitumor Activity
7%
Antiangiogenesis Therapy
7%
Autophagy
7%
Orthotopic Model
7%
EphA2
7%